Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Tela Bio Inc
TELACurrent price
2.35 USD
+0.11 USD (+4.91%)
Last closed
2.24 USD
Company
www.telabio.com
ISIN
US8723811084
Sector
Healthcare
Industry
Medical Devices
Exchange
NASDAQ
Capitalization
109 893 632 USD
Yield for 12 month
-55.91 %
1Y
3Y
5Y
10Y
15Y
TELA
TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. The company was incorporated in 2012 and is headquartered in Malvern, Pennsylvania. Address: 1 Great Valley Parkway, Malvern, PA, United States, 19355
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
9.20 USDP/E ratio
–Dividend Yield
–Current Year
+58 453 000 USD
Last Year
+41 418 000 USD
Current Quarter
+18 957 000 USD
Last Quarter
+16 091 000 USD
Current Year
+40 112 000 USD
Last Year
+27 044 000 USD
Current Quarter
+12 858 000 USD
Last Quarter
+11 073 000 USD
Key Figures TELA
1 year
3 years
5 years
10 years
EBITDA
-44 711 000 USD
Operating Margin TTM
Price to Earnings
–
Return On Assets TTM
-40.64 %
PEG Ratio
–
Return On Equity TTM
-342.04 %
Wall Street Target Price
9.20 USD
Revenue TTM
68 649 000 USD
Book Value
-0.25 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
25.90 %
Dividend Yield
–
Gross Profit TTM
27 848 000 USD
Earnings per share
-1.69 USD
Diluted Eps TTM
-1.69 USD
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-60.49 %
Dividend Analytics TELA
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Dividend History TELA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
–
Dividend CAGR 3Y
–
Dividend CAGR 5Y
–
Dividend CAGR 10Y
–
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
–
Forward Annual Dividend
– USD
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Stock Valuation TELA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
1.95
Price Sales TTM
1.60
Enterprise Value EBITDA
-5.01
Price Book MRQ
22.99
Financials TELA
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators TELA
For 52 weeks
2.30 USD
7.84 USD
50 Day MA
2.82 USD
Shares Short Prior Month
335 908
200 Day MA
4.12 USD
Short Ratio
1.28
Shares Short
285 027
Short Percent
0.98 %
BeatStart